Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis

European Respiratory Journal

Volumn 14, Issue 1, 1999, Pages 144-149

  Bont, L ^a   Heijnen, C J ^a   Kavelaars, A ^a   Van Aalderen, W M C ^b   Brus, F ^c   Draaisma, J Th M ^d   Geelen, S M ^a   Van Vught, H J ^a   Kimpen, J L L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c CPRLab   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Cytokines; Disease severity; Respiratory syncytial virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 8; PHYTOHEMAGGLUTININ;

AGE; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; BRONCHIOLITIS, VIRAL; CELLS, CULTURED; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-8; MALE; PHYTOHEMAGGLUTININS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH2 CELLS;

EID: 0032824131     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14a24.x     Document Type: Article

References (35)

1. McDonald NE, Hall CB, Suffin SC, Alexon C, Harris PJ, Manning JA. Respiratory syncytial virus infection in infants with congenital heart disease. N Engl J Med 1982: 307: 397-400.
2. Hall CB, Kopelman AE, Douglas RG, Geiman JM, Meagher MP. Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300: 393-396.
3. Opavski MA, Stephens D, Wang EEL. Testing models predicting severity of respiratory syncytial virus infections on the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Arch Pediatr Adolesc Med 1995; 149: 1217-1220.
4. Kimpen JLL. Respiratory syncytial virus immunology. Pediatr Allergy Immunol 1996; 7 (Suppl. 9): 86-90.
5. Openshaw PJM. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin Immunopathol 1995; 17: 187-201.
6. Welliver RC, Wong DT, Sun M, Middleton EJR, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305: 841-846.
7. Garofalo RP, Ahlstedt DA, Welliver RC. Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease. Pediatr Allergy Immunol 1994; 5: 111-117.
8. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88: 1026-1033.
9. Hussell T, Spender IC, Georgiou A, O'Garra A, Openshaw PJM. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J General Virol 1996; 77: 2447-2455.
10. Connors M, Kulkarni AB, Firestone CY, et al. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol 1992; 66: 7444-7450.
11. Isaacs D, Bangham CRM, McMichael AJ. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 1987; ii: 769-771.
12. Welliver RC, Kaul A, Ogra PL. Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr 1979; 94: 370-375.
13. Roman M, Calhoun WJ, Himton KL, et al. Respiratory syn-cytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156: 190-195.
14. Isaacs D. Production of interferon in respiratory syncytial virus bronchiolitis. Arch Dis Child 1989; 64: 92-95.
15. Folkerts G, Busse WW, Nijkamp FP, Sorkness RL, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998; 157: 1708-1720.
16. Welliver RC, Duff AL. The relationship of RSV-specific immunoglobulin E-antibody responses in infancy, recurrent wheezing and pulmonary function at age 7-8 years. Pediatr Pulmonol 1993; 15: 19-27.
17. Umetsu DT, DeKruyff RH. Th1 and Th2 cd4+ cells in human allergic diseases. J Allergy Clin Immunol 1997; 100: 1-6.
18. Madge P, Paton JY, McColl JH, Mackie PLK. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340: 1079-1083.
19. Wilson CB. Immunological basis for increased susceptibility of the neonate to infection. JPediatr 1986; 108: 1-12.
20. Burchett SK, Corey L, Mohan KM, Westall J, Ashley R, Wilson CB. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 1992; 165: 813-818.
21. Starr SE, Toplin MD, Friedman HM. Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis 1979; 140: 500-505.
22. Smith S, Jacobs RF, Wilson CB. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr 1997; 131: 16-26.
23. Holt PG. Postnatal maturation of immune competence during infancy and childhood. Pediatr Allergy Immunol 1995; 6: 59-70.
24. Hayward AR, Groothuis JR. Development of T cells with memory phenotype in infancy. Adv Exp Med Biol 1991; 310: 71-76.
25. Nonoyama S, Penix LA, Edwards CE. Dimished expression of CD40 ligand by activated neonatal T cells. J Clin Invest 1995; 95: 66-75.
26. Lewis DB, Yu CC, Meyer J, English BK, Kahn SJ, Wilson CB. Cellular and molecular mechanisms for reduced interleukin 4 and interferon gamma production by neonatal T cells. J Clin Invest 1991; 87: 194-202.
27. Roberts NJ. Different effects of influenza virus, respiratory syncytial virus, and sendai virus on human lymphocytes and macropohages. Infect Immun 1982; 35: 1142-1146.
28. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increases cytokines and c-fos mRNA expression in an isolated rat model. J Clin Invest 1997; 99: 944-952.
29. Sims DG, Downham MA, Gardner PS. Study of 8-yr-old children with a history of respiratory syncytial virus bronchiolitis in infancy. BMJ 1978; 1: 11-17.
30. Shute J, Vrugt B, Lindley IJD, et al. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997; 153: 1877-1883.
31. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child 1995; 72: F90-F96.
32. Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol 1995; 268: L117-L122.
33. Erger RA, Casale TB. Interleukin-8 plays a significant role in IgE-mediated lung inflammation. Eur Respir J 1998; 11: 299-305.
34. Teran LM, Johnston SL, Schroder JM, Church MK, Holgate ST. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997; 155: 1362-1366.
35. Arnold R, Werner F, Humbert B, Werchau H, Konig W. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF alpha) release and respiratory burst in human granulocytes. Immunology 1994; 82: 184-191.